NKX2-3 Transcriptional Regulation of Endothelin-1 and VEGF Signaling in Human Intestinal Microvascular Endothelial Cells by Yu, Wei et al.
NKX2-3 Transcriptional Regulation of Endothelin-1 and
VEGF Signaling in Human Intestinal Microvascular
Endothelial Cells
Wei Yu
1, John P. Hegarty
1, Arthur Berg
2,X iC h e n
4, Gail West
5, Ashley A. Kelly
1, Yunhua Wang
1, Lisa S.
Poritz
1,3, Walter A. Koltun
1*, Zhenwu Lin
1*
1Department of Surgery, Pennsylvania State University, Hershey, Pennsylvania, United States of America, 2Center for Statistical Genetics, Department of Public Health
Sciences, Pennsylvania State University, Hershey, Pennsylvania, United States of America, 3Department of Cellular & Molecular Physiology, Pennsylvania State University,
Hershey, Pennsylvania, United States of America, 4Department of Biostatistics, Vanderbilt University, Nashville, Tennessee, United States of America, 5Department of
Pathobiology, Lerner Research Institute, the Cleveland Clinic Foundation, Cleveland, Ohio, United States of America
Abstract
Background: NKX2-3 is associated with inflammatory bowel disease (IBD). NKX2-3 is expressed in microvascular endothelial
cells and the muscularis mucosa of the gastrointestinal tract. Human intestinal microvascular endothelial cells (HIMECs) are
actively involved in the pathogenesis of IBD and IBD-associated microvascular dysfunction. To understand the cellular
function of NKX2-3 and its potential role underlying IBD pathogenesis, we investigated the genes regulated by NKX2-3 in
HIMEC using cDNA microarray.
Methodology/Principal Findings: NKX2-3 expression was suppressed by shRNA in two HIMEC lines and gene expression
was profiled by cDNA microarray. Pathway Analysis was used to identify gene networks according to biological functions
and associated pathways. Validation of microarray and genes expression in intestinal tissues was assessed by RT-PCR. NKX2-
3 regulated genes are involved in immune and inflammatory response, cell proliferation and growth, metabolic process, and
angiogenesis. Several inflammation and angiogenesis related signaling pathways that play important roles in IBD were
regulated by NKX2-3, including endothelin-1 and VEGF-PI3K/AKT-eNOS. Expression levels of NKX2-3, VEGFA, PI3K, AKT, and
eNOS are increased in intestinal tissues from IBD patients and expression levels of EDN1 are decreased in intestinal tissues
from IBD patients. These results demonstrated the important roles of NKX2-3, VEGF, PI3K, AKT, eNOS, and EDN1 in IBD
pathogenesis. Correlation analysis showed a positive correlation between mRNA expression of NKX2-3 and VEGFA and a
negative correlation between mRNA expression of NKX2-3 and EDN1 in intestinal tissues from IBD patients.
Conclusion/Relevance: NKX2-3 may play an important role in IBD pathogenesis by regulating endothelin-1 and VEGF
signaling in HIMECs.
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Introduction
Crohn’s disease (CD) and ulcerative colitis (UC), the two main
subtypes of inflammatory bowel disease (IBD), are chronic,
relapsing inflammatory disorders of the gastrointestinal tract.
Genetics play an important role in the development of IBD [1].
NKX2-3 (NK2 transcription factor related, locus 3) has been shown
to be associated with both CD and UC by recent genome-wide
association studies [2,3].
NKX2-3 is a member of the Nkx family of homeodomain
transcription factors that play critical roles in regulating tissue-
specific gene expression essential for determining tissue differen-
tiation, as well as the temporal and spatial patterns of development
[4,5]. During development, NKX2-3 is primarily expressed in the
midgut and hindgut mesoderm and spleen, as well as in
pharyngeal endoderm [6,7,8]. Analysis of NKX2-3-deficient mice
has revealed a critical role for this homeobox transcription factor
in spleen development and organization [9], and in establishing
the correct environment for normal B cell development and T cell
dependent immune response [10]. NKX2-3 is also essential for
normal small intestine development and function [11]. NKX2-3 is
also expressed in microvascular endothelial cells within the lamina
propria and submucosa of the intestine, where it is required for
expression of the lymphocyte adhesion molecule MAdCAM-1 in
the mouse [9].
Microvascular endothelial cells have a critical ‘‘gatekeeper’’ role
in the inflammatory process through their ability to recruit
circulating immune cells to foci of inflammation. Endothelial
activation in response to cytokines and bacterial products results in
cell adhesion molecule expression and chemokine production,
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across the vascular wall. Intestinal microvascular endothelial cells
are recognized as a cell population actively involved in the
pathogenesis of inflammatory bowel diseases (IBD) and IBD-
associated microvascular dysfunction [12].
Transcription factors can regulate the expression of downstream
genes. Recently, we found that the expression of NKX2-3 is up-
regulated in intestinal tissues and B cells from CD patients [13]
and subsequently identified many inflammation and immune-
response genes regulated by NKX2-3 in B cell lines from a CD
patient. These included several genes which also have important
functions in endothelial cells, such as endothelin-1 (EDN1), ASS1,
and KLF2 [14]. Since endothelial cells play a key role in mucosal
immune homeostasis and NKX2-3 is expressed in intestinal
endothelial cells, we further performed cDNA microarray to
identify genes regulated by NKX2-3 in two human intestinal
microvascular endothelial cell lines (HIMEC).
Results
Suppression of NKX2-3 expression in 2 HIMEC lines
pSUPER.retro.puro.shRNA-NKX2-3 and empty vector were
transfected into 21B and 432 HIMEC. RT-PCR results showed
that mRNA expression levels of NKX2-3 in the two shRNA-NKX2-
3 cells were significantly reduced compared with the empty vector
cells (control cells) 48 hours after transfection (Fig. 1).
Identification of genes regulated by NKX2-3
To analyze the effects of NKX2-3 knockdown on gene
expression and identify genes with altered expression levels, cDNA
microarray analysis was conducted with NKX2-3 knockdown and
control cells from two HIMEC. Stringent criteria (fold change
$1.5, up or down, p,0.0005) were used to filter the differentially
expressed genes. The expression levels of 1746 genes were affected
by NKX2-3 knockdown (935 down-regulated and 811 up-
regulated) in the HIMEC 21B cell line as compared to control,
and 1603 genes were affected by NKX2-3 knockdown (741 down-
regulated and 862 up-regulated) in the HIMEC 432 cell line as
compared to control. A total of 1000 shared genes were found to
be affected by NKX2-3 knockdown in both HIMEC, including 996
(99.6%) genes in the same direction (432 genes down-regulated
and 564 genes up-regulated by NKX2-3 knockdown in both
HIMEC), and only 4 genes in the opposite direction. Taken
together, the transcriptional profile of genes affected by NKX2-3
knockdown was highly consistent for both HIMEC. Table 1 shows
the top 100 down-regulated and top 100 up-regulated genes by
NKX2-3 knockdown with average fold changes in the two cell lines.
In order to characterize the top genes affected by NKX2-3
knockdown, they were assigned to ontological functional groups
based on IPA and references in the literature. These 200 genes
grouped primarily within the following functional categories,
which are listed as such in Table 1: immune and inflammatory
response; cell growth and proliferation; metabolic process; cell
adhesion; transcription regulation; transport and structure; and
angiogenesis. Since the NKX2-3 transcription factor is associated
with IBD and is up-regulated in CD patients [13], it is reasonable
to assume that NKX2-3 could play a role in IBD pathogenesis by
regulating inflammation-related genes. In fact, among the 200
genes regulated by NKX2-3, 70 genes were immune and
inflammatory response genes, including IL8 (array ratio 0.4) and
KLF2 (array ratio 3.92). Angiogenesis plays an important role in
endothelial cell participation in inflammation [15], ANGPT2 is
down-regulated (array ratio 0.18) and FGF2 is up-regulated (array
ratio 4.0) by NKX2-3 knockdown.
Identification of pathways regulated by NKX2-3
To assess the global effects of NKX2-3 on gene expression, IPA
was used to systematically visualize the relationships among genes
regulated by NKX2-3 knockdown. The 25 pathways most affected
by NKX2-3 are shown in Fig. 2A. G-Protein Coupled Receptor
Signaling (p=1.71610
214), Axonal Guidance Signaling
(p=5.80610
211), and ERK/MAPK Signaling (p=5.42610
29)
were the top three canonical pathways affected by NKX2-3
knockdown.
We previously found that knockdown of NKX2-3 in human B
cells [14] significantly affected the expression of genes, including
EDN1 and NOS, known to have important roles in endothelial cell
function. We sought to investigate whether NKX2-3 knockdown
would affect important genes and signaling pathways in HIMEC.
EDN1 was found to be up-regulated by NKX2-3 knockdown in
both HIMEC (array ratio 1.2/1.3, p,0.05). NKX2-3 knock-
down significantly affected genes within the endothelin-1
pathway (p=1.02 610
24), which was among the top 25
pathways affected by NKX2-3 (Fig. 2A). Fig. 2B illustrates the
genes in the endothelin-1 pathway affected by NKX2-3
knockdown. NKX2-3 knockdown activated MAPK through
EDN1-PLCb-PLC pathway, thus regulated inflammation
response and cell proliferation.
Nitric oxide (NO) which is generated by NO synthase (NOS)
may play an important role in the pathogenesis of IBD [15].
Production of NO (in macrophages) is among the top 10 pathways
affected by NKX2-3 (Fig. 2A). eNOS is down-regulated by NKX2-3
knockdown in both HIMEC (array ratio 21.3/22.7, p,0.0001).
IPA analysis showed that the regulation of eNOS can be through
VEGF-PI3K/AKT pathway and that this pathway is significantly
affected by NKX2-3 knockdown (p=5.45610
23) (Fig. 2C). Fold
changes of key genes in this pathway regulated by NKX2-3
knockdown in HIMEC are: VEGF (21.3/21.3), PI3K (21.5/
21.7), and AKT (21.35/21.35).
Validation of cDNA microarray by RT-PCR
RT-PCR on 10 genes (involved in or affected by EDN1 and
VEGF pathways) was carried out as an independent verification
method of the microarray results. Among the 10 genes, seven
(MAdCAM1, AKT, VCAM1, VEGF, PLCB1, PI3K, and eNOS) were
down-regulated by NKX2-3 knockdown in both HIMEC, and
three (EDN1, ADM, and CASP1) were up-regulated by NKX2-3
knockdown in 2 HIMEC detected by cDNA microarray. All RT-
PCR results were consistent with the microarray data. The fold
changes in microarray between the 2 NKX2-3 knockdown cell lines
and 2 control HIMEC lines were: MAdCAM1 (21.2;21.2), AKT
Figure 1. NKX2-3 mRNA expression is suppressed by shRNA in
21B and 432 HIMEC. pSUPER.retro.puro.shRNA-NKX2-3 and empty
vector were transfected into two HIMEC. 48 hours after transfection,
RNA was isolated and analyzed by RT-PCR in two knockdown HIMEC
compared with controls. GAPDH expression served as a control.
doi:10.1371/journal.pone.0020454.g001
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Gene Fold p-value Gene Fold p-value Gene Fold p-value Gene Fold p-value
Cell growth and
proliferation
Transport and structure Inflammation and immune response Inflammation and immune response
PIM3 0.3 2.31E-06 SYT11 0.35 3.66E-07 TNFRSF10D 0.31 3.54E-07 SAMD9 7.31 2.01E-10
TFPI2 0.32 3.94E-06 KRT81 0.4 3.31E-07 TNFSF18 0.32 6.43E-05 STAT1 7.72 1.98E-09
NR2F1 0.37 4.64E-07 RPS23 0.4 2.97E-07 CERK 0.33 1.39E-06 TAP2 7.83 7.33E-10
EIF4B 0.38 2.68E-07 EXOC6 0.47 2.09E-06 FAM172A 0.37 1.94E-07 PSMB8 8.22 1.84E-10
GHR 0.39 3.69E-07 RPL23 0.47 1.33E-06 YPEL2 0.39 0.000952 UBE2L6 8.33 9.08E-10
HMMR 0.39 3.79E-06 RPS29 0.48 2.41E-06 PAPSS2 0.39 8.84E-06 PTGS2 8.63 2.77E-11
REEP1 0.4 2.86E-07 ADAP1 3.29 2.36E-08 IL8 0.4 7.63E-06 GBP1 9.24 2.23E-08
ZMAT3 0.41 3.60E-07 SLC25A28 3.71 1.99E-07 UACA 0.4 3.05E-05 PARP9 9.46 6.09E-10
MMP7 0.42 3.43E-06 RTP4 6.47 0.000111 GIMAP7 0.41 9.24E-07 SP110 9.83 1.31E-10
GDF15 0.42 1.22E-05 GJD3 7.95 0.000154 HES2 0.41 2.05E-07 TAP1 10.62 7.18E-11
MFNG 0.42 2.32E-05 SLC40A1 0.41 2.59E-07 USP18 11.2 9.63E-11
AGAP3 0.43 6.31E-07 TNFAIP8L1 0.43 3.66E-07 DDX58 11.39 3.09E-08
TMEM158 0.44 1.25E-05 Cell adhesion F2RL1 0.43 0.000121 HLA-B 11.89 8.66E-12
UNC5A 0.44 7.44E-05 CD36 0.43 5.14E-07 PRIC285 12.35 1.67E-10
SHMT2 0.44 1.55E-06 POSTN 0.22 6.28E-09 PLD1 0.44 2.12E-07 PSMB9 14.18 1.73E-10
FAM198B 0.45 3.44E-06 MMRN1 0.35 3.33E-06 CBS 0.46 3.70E-06
HNRNPA0 0.46 6.11E-05 CXADR 0.36 7.75E-07 CEP55 0.47 3.69E-06
PAWR 0.46 4.71E-05 SRPX 0.37 7.57E-06 GNG12 0.48 5.21E-05 Others
DCLK1 0.47 7.04E-07 FLRT2 0.46 8.02E-06 TNFSF4 0.48 1.00E-05
TTC3 0.47 5.53E-07 AIF1L 3.41 8.77E-08 ARHGDIB 0.49 2.55E-05 ANKRD55 0.18 1.07E-07
TFF3 0.47 1.73E-05 CLEC1A 0.49 1.96E-05 C2CD4B 0.22 2.48E-08
PTPRE 0.47 4.31E-06 CXCL16 3.19 1.04E-05 KIAA0114 0.27 2.03E-08
UBE4B 0.47 2.02E-06 Transcription regulation GCH1 3.32 5.31E-05 NT5DC2 0.28 8.23E-09
CDKN3 0.48 0.000101 UNC93B1 3.46 1.36E-06 EIF4BP7 0.29 3.73E-07
CCNB2 0.49 2.92E-05 SDPR 0.44 1.95E-06 CD68 3.51 3.49E-07 FLJ41200 0.29 2.64E-08
ANLN 0.49 3.85E-05 HOXD1 0.45 0.000147 TRIM21 3.62 9.21E-06 C13orf33 0.34 7.43E-06
LGMN 3.23 4.42E-07 ZNFX1 3.52 2.22E-06 APOBEC3G 3.67 5.26E-06 EIF4BP3 0.38 1.42E-07
SEMA3A 3.25 2.19E-06 BATF2 4.11 1.75E-06 TRIM5 3.82 4.78E-05 FBN2 0.39 5.49E-06
PNPT1 3.44 2.45E-05 KLF2 3.92 7.66E-06 C7orf41 0.4 5.68E-07
MAP2 3.57 4.49E-09 PLSCR1 4.05 2.58E-08 SNHG9 0.41 0.000156
PMAIP1 3.65 3.66E-08 Metabolic process MYD88 4.28 1.98E-06 WRB 0.42 1.18E-06
EIF2AK2 3.73 9.30E-09 CD38 4.28 6.55E-08 BCYRN1 0.42 0.000157
HEY1 3.85 2.33E-07 ACO1 0.2 8.00E-07 CX3CL1 4.33 0.000209 ZNF704 0.44 5.90E-07
CSRNP1 3.87 1.55E-06 HSD17B2 0.23 2.48E-06 STAT2 4.34 1.08E-05 ANKRD37 0.46 5.41E-06
C8orf4 3.95 5.53E-06 PHGDH 0.29 1.86E-08 PLEKHA4 4.37 1.83E-05 HNRPA1L-2 0.46 8.27E-06
XAF1 4.17 2.88E-06 PSAT1 0.3 1.24E-07 IFNB1 4.37 3.68E-06 TCTEX1D2 0.47 0.000153
SERPINE2 4.33 2.29E-08 ASNS 0.31 1.09E-07 FCN3 4.38 0.000198 CENPW 0.48 7.38E-05
HEY2 4.6 4.55E-08 GALNTL2 0.33 7.00E-06 F2RL3 4.44 2.45E-07 NETO2 0.48 1.93E-05
PARP10 5.54 5.42E-08 PKIA 0.34 7.05E-05 ZC3HAV1 4.6 5.95E-07 C8orf45 0.48 8.75E-05
CRYAB 6.8 8.25E-06 MYO5A 0.38 5.34E-05 HCG4 4.61 2.85E-09 MAMDC2 3.19 6.34E-07
KLF4 6.86 6.09E-10 TXNDC12 0.4 1.43E-07 HLA-C 4.63 1.63E-09 FBXO6 3.26 7.21E-08
LY6E 7.47 1.94E-10 SNCAIP 0.41 0.000257 GBP2 4.71 4.44E-08 C1orf74 3.48 0.000186
TMEM100 15.53 3.36E-07 CHST7 0.44 7.79E-07 SMAD7 4.78 1.31E-06 USP41 3.52 3.72E-06
MCTP1 0.46 0.000231 NT5C3 4.8 1.92E-07 C19orf66 3.92 2.77E-08
FAR2 0.48 0.000238 HLA-H 5.39 4.83E-10 HIST2H2AC 4.18 5.43E-08
Angiogenesis PRSS12 0.48 1.43E-06 TRIM22 5.49 9.22E-08 GCA 5.14 5.15E-06
BCHE 0.49 3.81E-06 DHX58 5.58 1.57E-06 HIST2H2AA3 5.17 2.92E-09
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PLCB1 (21.6;21.5), PI3K (21.5;21.7), eNOS (21.3;22.7),
EDN1 (1.2;1.3), ADM (1.9;2.1), and CASP1 (4.6;5). The PCR
ratios between the 2 NKX2-3 knockdown cell lines and 2 control
HIMEC lines were: MAdCAM1 (23;24), AKT (23;23.5), VCAM1
(23;23), VEGFA (24;23), PLCB1 (23.5;23.5), PI3K (23;22.8),
eNOS (23;24.5), EDN1 (2.5;3), ADM (3.5;3), and CASP1 (4.5;4.8)
(Fig. 3).
Gene Fold p-value Gene Fold p-value Gene Fold p-value Gene Fold p-value
ANGPT2 0.18 1.42E-05 ADAMTSL2 3.2 1.26E-06 IL18BP 5.66 3.92E-09 HIST2H2AA4 5.28 2.11E-09
SRPX2 0.33 0.000284 TIPARP 3.28 1.18E-07 HLA-F 5.79 2.68E-10 RNF213 6.6 1.03E-06
TRPC6 0.33 1.08E-07 PLA1A 4.75 3.24E-08 CASP1 5.82 5.35E-10 DDX60L 6.75 1.14E-08
BTG1 0.43 3.66E-05 GMPR 4.8 5.63E-08 PARP12 6.28 1.97E-09 LYPD1 6.75 3.01E-05
BMP4 0.48 2.53E-05 LAP3 6.07 9.20E-09 IDO1 6.93 1.77E-08 DDX60 7.87 2.71E-09
ANGPTL4 3.37 1.01E-08 UBA7 6.64 9.54E-08 HCP5 6.99 3.95E-10 FAM46A 8.63 4.81E-06
TYMP 3.38 1.13E-08 CMPK2 10.3 5.63E-08 PARP14 7.01 1.24E-08 MT1M 8.77 6.76E-11
FGF2 4 5.16E-05 ALPL 12.12 0.000474 IL7R 7.06 3.94E-05 SAMD9L 9.07 1.22E-08
doi:10.1371/journal.pone.0020454.t001
Table 1. Cont.
Figure 2. An interaction network generated using IPA analysis shows genes regulated by NKX2-3 in HIMEC. (A) The top 25 signaling
pathways affected by NKX2-3 knockdown. (B) The EDN1 pathway is regulated by NKX2-3 in 2 HIMEC. IPA analysis shows genes up-regulated (red) and
down-regulated (green) by NKX2-3 knockdown. (C) The VEGF-PI3K/AKT-eNOS pathway is regulated by NKX2-3 in 2 HIMEC. IPA analysis shows genes
up-regulated (red) and down-regulated (green) by NKX2-3 knockdown in the VEGF-PI3K/AKT-eNOS pathway.
doi:10.1371/journal.pone.0020454.g002
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in intestinal tissues from IBD patients
NKX2-3 is reported to be up-regulated in intestinal tissues in CD
patients [13] and VEGF showed markedly enhanced expression
levels in both CD and UC tissues [16], while EDN1 showed both
increased levels [17] and decreased levels in intestinal tissues from
IBD patients [18]. Since NKX2-3 can affect the endothelin-1 and
VEGF-PI3K/AKT-eNOS pathways (Fig. 2B and C) in HIMEC,
we examined mRNA expression levels of the 6 genes in diseased
and adjacent normal intestinal tissues from IBD patients to study
clinical implication of NKX2-3 and its regulated genes. 31 CD and
32 UC patients are for this study (Table 2).
As shown in Fig. 4A, the mRNA expression levels of NKX2-3,
VEGFA, PI3K, AKT, and eNOS are significantly increased in
diseased intestinal tissues compared with adjacent normal tissues in
CD patients. The overall mean NKX2-3 expressions were:
3.8862.42 (CD) vs. 2.1161.4 (normal) (p=0.0065); VEGFA
expressions were: 4.8615.57(CD) vs. 20.5567.43 (normal)
(p=0.0036); PI3K expressions were: 15.78635.76 (CD) vs.
1.9167.61 (normal) (p=0.0078); AKT expressions were:
10.32630.75 (CD) vs. 25.05624.58 (normal) (p=0.0164); and
eNOS expressions were: 11.13648.31(CD) vs. 220.22655.52
(normal) (p=0.0088). Expression levels of EDN1 are decreased
in diseased intestinal tissues compared with adjacent normal tissues
in CD patients: 216.82683.13 (CD) vs. 210.77626.94 (normal)
(p=0.7196).
As shown in Fig. 4B, the mRNA expression levels of NKX2-3,
VEGFA, PI3K, AKT, and eNOS are increased in diseased intestinal
tissues compared with adjacent normal tissues in UC patients. The
overall mean NKX2-3 expressions were: 4.2663.39 (UC) vs.
2.7861.68 (normal) (p=0.0387); VEGFA expressions were:
1.761.53 (UC) vs. 0.6563.13 (normal) (p=0.3572); PI3K
expressions were: 6.4667.63 (UC) vs. 3.7365.22 (normal)
(p=0.2942); AKT expressions were: 2365.63 (UC) vs.
226.79645.65 (normal) (p=0.5701); and eNOS expressions were:
0.6262.04 (UC) vs. 21.6765.19 (normal) (p=0.4203). Expression
levels of EDN1 are decreased in diseased intestinal tissues
compared with adjacent normal tissues in UC patients:
21.8568.7 (UC) vs. 0.9764.29 (normal) (p=0.0653).
Taken together, expression levels of NKX2-3, VEGFA, PI3K, AKT,
and eNOS are increased in intestinal tissues from IBD patients. On
theother hand,expression levels ofEDN1 aredecreasedin intestinal
tissues from IBD patients. Theseresults demonstrated theimportant
roles of these genes in IBD pathogenesis.
Figure 3. Validation of microarray results by RT-PCR in two NKX2-3 knockdown HIMEC. (A) RT-PCR analysis of mRNA expression levels of
10 genes in knockdown and control cells. EDN1, ADM, and CASP1 showed increased mRNA expression levels in NKX2-3 knockdown cells compared
with control cells; MAdCAM1, AKT, VCAM1, VEGF, PLCB1, PI3K, and eNOS showed decreased mRNA expression levels in NKX2-3 knockdown cells
compared with control cells. GAPDH expression served as a control. (B) Microarray results and corresponding RT-PCR for the 10 genes. The RT-PCR
product bands on the photograph were scanned by densitometry. The relative mRNA expression level was expressed as gene expression levels in
knockdown cells compared to gene expression levels in control cells.
doi:10.1371/journal.pone.0020454.g003
Table 2. Patient demographic data.
Crohn’s disease Ulcerative colitis
(n=31) (n=32)
Sex M/F 14/17 16/16
Family history for IBD (yes/no) 8/23 5/27
Average age 39.9615.1 48.4616.3
IBD location
terminal ileum 16 1
small bowel 5 1
colon 8 26
cecum 2 3
rectum 0 1
doi:10.1371/journal.pone.0020454.t002
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VEGFA in intestinal tissues from IBD patients
There are seven members of the vascular endothelial growth
factors (VEGFs) family, ie, VEGF-A, -B, -C, -D, -E, -F, and
placental growth factor. VEGFA is crucially involved in several
chronic inflammatory disorders in which it not only promotes
pathologic angiogenesis but directly fosters inflammation [19,20].
VEGFA has been reported to over-express in humans with IBD
[21,22,23]. VEGFA was down-regulated by NKX2-3 knockdown in
2 HIMEC (Fig. 2C and 3). Since both NKX2-3 and VEGFA are up-
regulated in intestinal tissues from IBD patients (Fig. 4), next we
examined whether NKX2-3 expression was correlated with VEGFA
expression in IBD patients. We examined mRNA expression levels
of NKX2-3 and VEGFA in diseased and adjacent normal intestinal
tissues from 30 CD and 30 UC patients. Fold change results of
normalized NKX2-3 or VEGFA were summarized as a ratio of
medians (CD or UC: adjacent normal tissue) in every patient.
Correlation analysis showed a positive correlation between
expression of NKX2-3 and VEGFA (r=0.681, p,0.0001) for CD
(Fig. 5A) and for UC (r=0.509, p,0.0001) (Fig. 5B).
Negative correlation of gene expression of NKX2-3 with
EDN1 in intestinal tissues from IBD patients
Endothelin-1 (EDN1) is a vasoactive peptide implicated in a
number of pathological conditions, including human IBD [17].
EDN1 was up-regulated by NKX2-3 knockdown in 2 HIMEC by
cDNA microarray analysis (Fig. 2B) and this observation was
confirmed by RT-PCR (Fig. 3). Since NKX2-3 is up-regulated and
EDN1 is down-regulated in intestinal tissues from IBD patients
(Fig. 4), we examined whether NKX2-3 expression was correlated
with EDN1 expression in IBD patients. We examined mRNA
expression levels of NKX2-3 and EDN1 in diseased intestinal tissues
from 30 CD and 25 UC patients. Correlation analysis showed a
negative correlation between expression of NKX2-3 and EDN1 for
CD (r=20.353, p,0.01) (Fig. 6A) and for UC (r=20.442,
p,0.005) (Fig. 6B).
Discussion
Pathogenesis of IBD is not only restricted to those mediated by
classic immune cells, such as T and B cells [24], but also involves
nonimmune cells, including endothelial cells [15]. Endothelial cells
play a key role in mucosal immune homeostasis by regulating the
leukocytes migrating from the intravascular to the interstitial
space, thus highlighting the endothelium as one of the pillars in
inflammation pathogenesis [25]. The vascular response is a key
component of inflammation. Microvascular endothelial cells could
form capillary-like structures and display different functional sets
of adhesion molecules, distinct chemokine secretory patterns, and
activation of unique sets of genes in response to stress and
inflammatory stimuli [26].
In this study, we performed genome-wide gene expression
microarray analysis using two HIMEC with NKX2-3 knockdown,
and identified 1746 genes in 21B cells and 1603 genes in 432 cells
regulated by NKX2-3 knockdown. The regulation of these genes is
highly consistent between the two HIMEC. Most of the NKX2-3
regulated genes are involved in immune and inflammatory
response, cell proliferation and growth, metabolic process, and
angiogenesis. Various aspects of immunity contribute to the
development of an overall inflammatory immune response.
Chemokines control leukocyte trafficking during homeostasis as
well as inflammation. The migration of leukocytes into sites of
inflammation is crucial in the pathogenesis of IBD. The CXC
chemokine IL8/CXCL8 is down-regulated by NKX2-3 knock-
down in HIMEC. IL8 is expressed in leucocytes and endothelial
Figure 4. mRNA expression levels of 6 genes in intestinal tissues from CD and UC patients. (A) Comparison of mRNA expression levels of
6 genes in diseased vs. adjacent normal intestinal tissues from CD patients: NKX2-3 (n=30), VEGFA (n=30), PI3K (n=31), AKT (n=28), eNOS (n=24),
and EDN1 (n=30). RT-PCR was carried out on surgically excised diseased and adjacent normal intestinal tissues from CD patients. The RT-PCR product
bands on the photograph were scanned by densitometry. RT-PCR results were normalized by GAPDH as fold change for each patient. Data are
presented as the means. (B) Comparison of mRNA expression levels of 6 genes in diseased vs. adjacent normal intestinal tissues from UC patients:
NKX2-3 (n=30), VEGFA (n=32), PI3K (n=32), AKT (n=21), eNOS (n=23), and EDN1 (n=27). RT-PCR was carried out on surgically excised diseased and
adjacent normal intestinal tissues from UC patients. Data are presented as the means.
doi:10.1371/journal.pone.0020454.g004
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[27]. The expression level of IL8 is up-regulated in tissues after
ischaemic injury [28]. One of the most novel aspects that directly
implicates endothelial cell participation in inflammation is the
process of angiogenesis. It is now well established that angiogenesis
and microvascular remodeling are intrinsic components of the
tissue remodeling in chronic inflammatory diseases [15]. ANGPT2
(angiopoietin 2) is down-regulated by NKX2-3 knockdown in
HIMEC. ANGPT2 is responsible for the initiation of angiogenesis
through recruitment and proliferation of endothelial cells [29].
Elevated serum ANGPT2 levels in IBD patients have been
reported [30].
We used pathway analysis to systematically visualize the
relationships of genes regulated by NKX2-3 knockdown. The top
25 pathways affected by NKX2-3 knockdown included those
involved in inflammation and immune response, including the
EDN1 and NO pathways. Generation of nitric oxide (NO) by NO
synthase (NOS) is a central feature of chronic inflammatory
diseases in the gastrointestinal tract [15]. eNOS is down-regulated
by NKX2-3 knockdown in HIMEC. We identified that NKX2-3
regulated eNOS through the VEGF-PI3k/AKT pathway in
HIMEC. VEGF, PI3K, and AKT are all down-regulated by
NKX2-3 knockdown in HIMEC. A few reports have described
overexpression of VEGFA in human intestinal tissues with IBD
[21,22,23], but the functional significance of such up-regulation is
not yet understood. In murine colonic-derived endothelial cells,
VEGFA triggers an inflammatory phenotype by up-regulating
CAMs and inducing adhesion of neutrophils and T cells, thus
Figure 5. The correlation between the expression levels of NKX2-3 and VEGFA in intestinal tissues from IBD patients. (A) The
correlation between the expression levels of NKX2-3 and VEGFA in diseased and adjacent normal intestinal tissues from 30 CD patients. RT-PCR was
carried out on surgically excised intestinal tissues. The RT-PCR product bands on the photograph were scanned by densitometry. RT-PCR results were
normalized by GAPDH for each sample. Fold change results of normalized NKX2-3 or VEGFA were summarized as a ratio of medians (CD: adjacent
normal tissue) in every patient. Correlation coefficient (r) and p value are shown. (B) The correlation between the expression levels of NKX2-3 and
VEGFA in diseased and adjacent normal intestinal tissues from 30 UC patients.
doi:10.1371/journal.pone.0020454.g005
Figure 6. The correlation between the expression levels of NKX2-3 and EDN1 in intestinal tissues from IBD patients. (A) The correlation
between the expression levels of NKX2-3 and EDN1 in diseased intestinal tissues from 30 CD patients. RT-PCR was carried out on surgically excised
intestinal tissues. The RT-PCR product bands on the photograph were scanned by densitometry. RT-PCR results were normalized by GAPDH in every
patient. Correlation coefficient (r) and p value are shown. (B) The correlation between the expression levels of NKX2-3 and EDN1 in diseased intestinal
tissues from 25 UC patients.
doi:10.1371/journal.pone.0020454.g006
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[31]. One recent study showed that in vitro, VEGF-A induces
both angiogenic activity and an inflammatory phenotype in
human intestinal microvascular endothelial cells (HIMEC),
whereas overexpression in vivo increases disease severity and
blockade decreases disease severity in colitic mice [23]. Given that
the activation of this VEGF–eNOS angiogenesis pathway results
in maintenance production of NO, it is most likely to be implicated
in the regulation of NO-controlled gene expression, as well as the
NO-mediated angiogenic responses to VEGF. VEGF is known to
be a potent activator of endothelial cells and a critical factor for the
induction of angiogenesis during IBD development [23]. The
importance of the VEGF–eNOS pathway for regulating angio-
genesis and vascular remodeling makes these genes important for
IBD pathogenesis. Our results showed that mRNA expression
levels of NKX2-3, VEGFA, PI3K, AKT, and eNOS were increased in
intestinal tissues from IBD patients. And the positive correlation
between the expression levels of NKX2-3 and VEGFA in intestinal
tissues from IBD patients (Fig. 5) suggests a regulatory role of
NKX2-3 in VEGFA gene expression. The mechanism of regulation
of VEGF by NKX2-3 is not clear. NKX2-3 could regulate expression
of IL8, ANGPT2,KLF2, and KLF4 in HIMEC.IL8Stimulates VEGF
expression in endothelial cells [32] and ANGPT2 stimulates the
synthesis of VEGF [33]. The KLF2 and KLF4 transcription factors
have been shown to coordinate transcriptional programs important
for the establishment of an anti-inflammatory, vasodilatory, and
anti-thrombotic vascular endothelial phenotypes, thus acting as
critical regulators of endothelial homeostasis [34]. KLF2 and KLF4
regulate expressionofVEGF and eNOSinvascularendothelialcells
[34]. It is reasonable to speculate that NKX2-3 regulates VEGF
expression through IL8, ANGPT2, KLF2, and KLF4 or direct
regulation of VEGF. Although the role of NKX2-3 in IBD is still
unclear, its regulatory role in VEGF-eNOS strongly suggests that
NKX2-3 could be involved in IBD pathogenesis by regulating the
VEGF-PI3K/AKT-eNOS pathway.
Endothelin-1 (EDN1) is one of several vasoconstrictors that may
play a role in the progression of IBD. Endothelin-1 is expressed by
endothelial cells asa precursor peptide(proET-1)that is first cleaved
to bigET-1 and then to the mature 21-amino acid peptide. EDN1
acts through two receptors, ET-A and ET-B. EDN1 binding to ET-
Breceptorsinendothelialcellsinitiatesasignalingcascadethatleads
to nitric oxide (NO) and endothelial-derived relaxing factor
production. The signaling of NO production through ET-B
receptors via the G-protein bc subunit dimer has been linked to
AKT phosphorylation of eNOS. The G-protein Galpha12 has been
linked to increased levels of eNOS [35]. EDN1 increases leukocyte
adhesion to intestinal microvasculature [36], resulting in oxidant
stress and mucosal dysfunction [37]. Increased levels of EDN1 in
intestinal tissues from IBD patients have been reported [17].
However, other reports have indicated that EDN1 levels were
decreased in IBD [18,38]. We showed that expression of EDN1 was
down-regulated in intestinal tissues from IBD patients. Correlation
study confirmed the negative correlation between the expression
levels of NKX2-3 and EDN1 in intestinal tissues from IBD patients
(Fig. 6), suggesting a regulatory role of NKX2-3 in EDN1 gene
expression. NKX2-3 could negatively regulate EDN1 expression and
is thus involved in IBD pathogenesis.
In summary, this work identified many inflammation-related
genes and microvascular endothelial cell function related genes
that are regulated by NKX2-3 in HIMEC. Our present results
demonstrate that a decrease in NKX2-3 gene expression level can
profoundly affect the signaling pathways relevant to the patho-
genesis and progression of IBD such as the EDN1 and VEGF
signaling and PI3K/AKT-eNOS pathways. Further functional
studies of the genes and pathways affected by NKX2-3 using
HIMEC are underway to confirm and expand upon the current
work.
Materials and Methods
Cell lines
Two HIMEC (432 and 21B) were isolated from normal ileal
intestinal tissue from patients undergoing surgery at the Cleveland
Clinic Lerner Research Institute as approved by the Institutional
Review Board of University Hospitals of Cleveland. Cell lines were
cultured in MCDB131 medium (Invitrogen, USA) supplemented
with 20% fetal bovine serum (FBS), heparin, endothelial cell
growth factor and antibiotics. HIMEC were incubated at 37uCi n
an atmosphere of 5% CO2.
Transfection
A small hairpin RNA (shRNA) vector targeting human NKX2-3
was generated using the pSUPER vector system as described
previously [14,39]. The 19-nucleotide sequence within NKX2-3
targeted by the shRNA oligonucleotide pair was 59-AGGAA-
CATGAAGAGGAGCC-39. Forward and reverse primers were
synthesized containing this sequence in sense and antisense
orientations with an intervening linker. Forward and reverse
primers were annealed and ligated into the pSUPER.retro.puro
vector according to the manufacturer’s instructions (OligoEngine,
WA, USA).
pSUPER.retro.puro.shRNA-NKX2-3 and empty vector were
transfected into two HIMEC lines with TransPass
TM HUVEC
transfection reagent (New England BioLabs, USA) according to
the manufacturer’s instructions. Forty-eight hours posttransfection,
to confirm the suppression of NKX2-3 expression, mRNA from
was isolated from the transfected HIMEC lines for further
examination.
Microarray and data analysis
Illumina Human HT12 v 3 Expression BeadChips (Illumina,
CA) were used in this study. This BeadChip targets .25,000 genes
with .48,000 probes derived from the RefSeq (Build 36.2, rel22)
and UniGene (Build 99) databases. 300 ng of total RNA collected
from two independent cultures of control and shNKX2-3-
expressing HIMEC cells was reverse transcribed into cRNA and
biotin-UTP labeled using the Illumina Total Prep RNA
Amplification Kit (Ambion, Austin, TX). Microarray hybridiza-
tion, data collection, and analysis were performed at the Genomics
Core of the Cleveland Clinic Lerner Research Institute.
Raw data filtering and quantile normalization were performed
using the Bioconductor package lumi, a Beadarray specific software
package for Illumina microarray data. Due to the small sample
size, the moderated t-statistic implemented in the Bioconductor
LIMMA package was used to detect differentially expressed genes.
This statistic has the same interpretation as the standard t-statistic;
however, standard errors were calculated to shrink toward a
common value by empirical Bayes model to borrow information
across all genes [40]. The p-values from moderated t-tests were
adjusted by Benjamini and Hochberg’s method to control false
discovery rate. All data is MIAME (Minimum Information About
a Microarray Experiment) compliant and that the raw data has
been deposited in a MIAME compliant database (GEO at NCBI,
accession number GSE28656).
Ingenuity pathway analysis (IPA)
IPA was used to identify gene networks according to biological
functions and/or diseases in the Ingenuity Pathways Knowledge
NKX2-3 Regulates EDN1 and VEGF Signaling
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expression levels served as input to the Ingenuity Pathways
Analysis (IPA) Knowledge Base v4.0. Lists of top pathways
associated with genes with changes in expression relative to
controls were generated with corresponding Benjamini and
Hochberg’s p values. Expression data was overlaid upon canonical
pathways associated with altered gene expression.
Patients and intestinal tissue samples
Intestinal tissues were obtained from IBD patients undergoing
surgery at the Penn State Hershey Medical Center. All human
tissues were approved by the Human Subjects Protection Offices
of The Pennsylvania State University College of Medicine, and
were undertaken with the understanding and written consent of
each subject. Macroscopically normal areas of intestine and areas
of intestine with obvious disease were classified by a pathologist.
The intestinal tissues were immediately submerged in RNAlater
Solution (Ambion, CA, USA) and stored at 4uC overnight. Tissues
were stored frozen at 270uC until total RNA extraction.
RNA isolation and reverse transcription PCR
Total RNA was extracted from HIMEC and intestinal tissues
using the RNeasy mini kit (QIAGEN Sciences, MD, USA)
according to the manufacturer’s instructions. cDNA was synthe-
sized from 1.0 mg of total RNA using a Superscript III 1
st Strand
Synthesis Kit (Invitrogen, CA, USA).
Primer sequences are listed in table 3. Primers were designed
using Primer3 software. PCR amplifications were performed at
94uC for 30 seconds, 60uC for 45 seconds, and 72uC for
45 seconds for 35 cycles (all genes except GAPDH) or 26 cycles
(GAPDH), followed by a final extension at 72uC for 5 min. PCR
products were visualized on 2% agarose gels stained with ethidium
bromide. RT-PCR product bands were scanned by densitometry
and results were normalized by GAPDH for each cell line.
Statistical analysis
The paired data (RT-PCR results) were analyzed with a one
sample permutation t-test with 500,000 permutations. The
analysis was performed using R (version 2.12.0) and the
onet.permutation function in the R library DAAG (version 1.03).
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